ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
LENZ Therapeutics Inc

LENZ Therapeutics Inc (LENZ)

24.855
0.025
( 0.10% )
Updated: 13:57:48
Advanced chart
Rendering Error

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
24.855
Bid
24.85
Ask
24.94
Volume
33,597
24.47 Day's Range 25.15
14.42 52 Week Range 38.93
Market Cap
Previous Close
24.83
Open
24.72
Last Trade
2
@
24.895
Last Trade Time
14:00:06
Financial Volume
US$ 835,376
VWAP
24.8646
Average Volume (3m)
142,042
Shares Outstanding
27,500,892
Dividend Yield
-
PE Ratio
-5.46
Earnings Per Share (EPS)
-4.53
Revenue
-
Net Profit
-124.65M

About LENZ Therapeutics Inc

LENZ Therapeutics, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia. Its product candidates, LNZ100 and LNZ101, are preservative-free, single-use, once-daily eye d... LENZ Therapeutics, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia. Its product candidates, LNZ100 and LNZ101, are preservative-free, single-use, once-daily eye drops containing aceclidine and aceclidine plus brimonidine, respectively. LNZ100 and LNZ101 are under clinical evaluation in the registration-enabling Phase III CLARITY trials as potential therapies for the treatment of presbyopia, a condition impacting an estimated 1.8 billion people globally and 128 million people in the United States. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
LENZ Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker LENZ. The last closing price for LENZ Therapeutics was US$24.83. Over the last year, LENZ Therapeutics shares have traded in a share price range of US$ 14.42 to US$ 38.93.

LENZ Therapeutics currently has 27,500,892 shares outstanding. The market capitalization of LENZ Therapeutics is US$682.85 million. LENZ Therapeutics has a price to earnings ratio (PE ratio) of -5.46.

LENZ Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.4051.6564417177924.4525.8524.017746225.01320479CS
41.0354.3450881612123.8227.4623.5110547225.24403665CS
12-11.605-31.829402084536.4638.7721.3414204228.40068666CS
262.56511.507402422622.2938.9319.900115436127.14048153CS
528.87555.538172715915.9838.9314.4215680223.22354024CS
1568.87555.538172715915.9838.9314.4215680223.22354024CS
2608.87555.538172715915.9838.9314.4215680223.22354024CS

LENZ - Frequently Asked Questions (FAQ)

What is the current LENZ Therapeutics share price?
The current share price of LENZ Therapeutics is US$ 24.855
How many LENZ Therapeutics shares are in issue?
LENZ Therapeutics has 27,500,892 shares in issue
What is the market cap of LENZ Therapeutics?
The market capitalisation of LENZ Therapeutics is USD 682.85M
What is the 1 year trading range for LENZ Therapeutics share price?
LENZ Therapeutics has traded in the range of US$ 14.42 to US$ 38.93 during the past year
What is the PE ratio of LENZ Therapeutics?
The price to earnings ratio of LENZ Therapeutics is -5.46
What is the reporting currency for LENZ Therapeutics?
LENZ Therapeutics reports financial results in USD
What is the latest annual profit for LENZ Therapeutics?
The latest annual profit of LENZ Therapeutics is USD -124.65M
What is the registered address of LENZ Therapeutics?
The registered address for LENZ Therapeutics is 1201 NORTH MARKET ST, FL 18 P.O. BOX 1347, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the LENZ Therapeutics website address?
The website address for LENZ Therapeutics is www.lenz-tx.com
Which industry sector does LENZ Therapeutics operate in?
LENZ Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
US$ 11.2636
(177.43%)
133.27M
LYTLytus Technologies Holdings PTV Ltd
US$ 0.355
(59.48%)
206.82M
SINTSiNtx Technologies Inc
US$ 4.3601
(54.61%)
68.25M
EDITEditas Medicine Inc
US$ 2.63
(51.15%)
23.35M
BSLKBolt Projects Holdings Inc
US$ 0.7761
(43.24%)
21.45M
HCTIHealthcare Triangle Inc
US$ 0.441
(-38.74%)
2.63M
NKLANikola Corporation
US$ 0.472
(-38.37%)
102.9M
CNSPCNS Pharmaceuticals Inc
US$ 0.090749
(-36.32%)
72.54M
SHOTWSafety Shot Inc
US$ 0.2132
(-28.93%)
12.39k
BPTHBio Path Holdings Inc
US$ 0.151
(-28.10%)
2.02M
ADTXAditxt Inc
US$ 0.13
(18.18%)
548.94M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0646
(18.53%)
444.25M
SMCISuper Micro Computer Inc
US$ 66.03
(18.33%)
241.31M
LYTLytus Technologies Holdings PTV Ltd
US$ 0.355
(59.48%)
206.81M
JTAIJet AI Inc
US$ 11.11
(173.65%)
133.16M

LENZ Financials

Financials
Rendering Error

Your Recent History

Delayed Upgrade Clock